{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:30:06Z","timestamp":1793428206171,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"publisher","award":["2024RC3053"],"award-info":[{"award-number":["2024RC3053"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["Z2023055"],"award-info":[{"award-number":["Z2023055"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302586"],"award-info":[{"award-number":["82302586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ60480"],"award-info":[{"award-number":["2025JJ60480"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.talanta.2026.130744","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:26:55Z","timestamp":1791386815000},"page":"130744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Automated enzymatic hydrolysis\u2013magnetic-bead-assisted sequential extraction workflow for LC\u2013MS\/MS profiling of urinary aldosterone-pathway steroids"],"prefix":"10.1016","volume":"313","author":[{"given":"Bingchu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nijiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lyv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8421-349X","authenticated-orcid":false,"given":"Xiwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichen","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.talanta.2026.130744_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1055\/a-1938-4242","article-title":"Prevalence of primary aldosteronism in newly diagnosed hypertensive patients in primary care","volume":"130","author":"Asbach","year":"2022","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"5","key":"10.1016\/j.talanta.2026.130744_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eprac.2020.10.007","article-title":"Prevalence, subtype classification, and outcomes of treatment of primary aldosteronism: a prospective study in China","volume":"27","author":"Xu","year":"2021","journal-title":"Endocr. Pract."},{"issue":"8","key":"10.1016\/j.talanta.2026.130744_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med. J. Aust."},{"issue":"12","key":"10.1016\/j.talanta.2026.130744_bib4","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"10.1016\/j.talanta.2026.130744_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism \u2014 a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.talanta.2026.130744_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"10.1016\/j.talanta.2026.130744_bib7","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.talanta.2026.130744_bib8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.talanta.2026.130744_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.talanta.2026.130744_bib10","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/j.talanta.2026.130744_bib11","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1007\/s00259-025-07312-0","article-title":"Clinical value of CXCR4-targeted PET-CT in primary aldosteronism: a systematic review and meta-analysis","volume":"52","author":"Tang","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"6","key":"10.1016\/j.talanta.2026.130744_bib12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/er.2018-00262","article-title":"Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism","volume":"40","author":"Storbeck","year":"2019","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.talanta.2026.130744_bib13","doi-asserted-by":"crossref","first-page":"e1181","DOI":"10.1210\/clinem\/dgab751","article-title":"Plasma steroid profiling in patients with adrenal Incidentaloma[J\/OL]","volume":"107","author":"Berke","year":"2022","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"10","key":"10.1016\/j.talanta.2026.130744_bib14","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/HYPERTENSIONAHA.124.23029","article-title":"Steroidomics-based screening for primary aldosteronism: impact of antihypertensive drugs","volume":"81","author":"Constantinescu","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.talanta.2026.130744_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1548344","article-title":"Advances in the biochemical diagnostics of primary aldosteronism: from immunoassays to steroidomics and proteomics","volume":"16","author":"Szatko","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.talanta.2026.130744_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124012","article-title":"A LC-MS\/MS method for the simultaneous quantitative determination of aldosterone, its precursor 18-hydroxycorticosterone and its metabolite tetrahydroaldosterone in human urine","volume":"1234","author":"Dong","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2026.130744_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchy.2020.100029","article-title":"The 2020 Italian society of arterial hypertension (SIIA) practical guidelines for the management of primary aldosteronism","volume":"5","author":"Rossi","year":"2020","journal-title":"Int. J. Cardiol. Hypertension"},{"issue":"1","key":"10.1016\/j.talanta.2026.130744_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1507\/endocrj.EJ25-0165","article-title":"Japan endocrine society clinical practice guideline for the diagnosis and management of pheochromocytoma and paraganglioma 2025","volume":"73","author":"Tanabe","year":"2026","journal-title":"Endocr. J."},{"issue":"3","key":"10.1016\/j.talanta.2026.130744_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2011-2384","article-title":"18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the diagnosis of primary aldosteronism and its subtypes","volume":"97","author":"Mulatero","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.talanta.2026.130744_bib20","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Peripheral plasma 18-Oxocortisol can discriminate unilateral adenoma from bilateral diseases in primary aldosteronism patients","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.talanta.2026.130744_bib21","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1038\/s41440-025-02375-w","article-title":"Diagnostic performance of 24-hour urinary aldosterone for primary aldosteronism in patients with or without discontinuation of antihypertensive medications","volume":"48","author":"You","year":"2025","journal-title":"Hypertens. Res.: Off. J. Japanese Soc. Hypertension"},{"issue":"5","key":"10.1016\/j.talanta.2026.130744_bib22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1515\/cclm-2023-0250","article-title":"A novel LC-MS\/MS-based assay for the simultaneous quantification of aldosterone-related steroids in human urine","volume":"62","author":"Vogg","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.talanta.2026.130744_bib23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0895-7061(03)00858-6","article-title":"Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study","volume":"16","author":"Abdelhamid","year":"2003","journal-title":"Am. J. Hypertens."},{"issue":"1A","key":"10.1016\/j.talanta.2026.130744_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-4731(83)80046-6","article-title":"Aldosterone metabolites and possible aldosterone precursors in hypertension","volume":"19","author":"Vecsei","year":"1983","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.talanta.2026.130744_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123030","article-title":"Liquid chromatography-tandem mass spectrometry (LC-MS\/MS) based assay for the simultaneous quantification of 18-hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in human plasma","volume":"1188","author":"Chen","year":"2022","journal-title":"J. Chromatogr. B"},{"issue":"8","key":"10.1016\/j.talanta.2026.130744_bib26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/clinchem\/hvad065","article-title":"A novel enzymatic hydrolysis method for urine aldosterone quantification: a case for reassessing clinical cut-offs of primary aldosteronism","volume":"69","author":"Yazdanpanah","year":"2023","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.talanta.2026.130744_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5694","article-title":"Simultaneous quantitation of urine aldosterone and tetrahydroaldosterone in healthy Chinese subjects using a validated LC-MS\/MS method","volume":"37","author":"Cheng","year":"2023","journal-title":"Biomed. Chromatogr.: BMC (Biomed. Chromatogr.)"},{"issue":"7\/8","key":"10.1016\/j.talanta.2026.130744_bib28","first-page":"386","article-title":"An abbreviated history of aldosterone metabolism, current and future challenges","volume":"131","author":"Gomez-Sanchez","year":"2023","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.talanta.2026.130744_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchromb.2019.03.012","article-title":"Establishment of a rapid and simple liquid chromatography tandem mass spectrometry method for measuring aldosterone in urine","volume":"1113","author":"Yin","year":"2019","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.talanta.2026.130744_bib30","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-17-0563","article-title":"Diagnosis of endocrine disease: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?[J\/OL]","volume":"178","author":"Lenders","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.talanta.2026.130744_bib31","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1515\/cclm-2016-0841","article-title":"Evaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS\/MS","volume":"55","author":"Lin","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.talanta.2026.130744_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2025.344403","article-title":"Enzymatic hydrolysis combined with chemiluminescence immunoassay: foresight for automated and rapid urinary aldosterone detection","volume":"1371","author":"Zhong","year":"2025","journal-title":"Anal. Chim. Acta"},{"issue":"8","key":"10.1016\/j.talanta.2026.130744_bib33","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1210\/js.2018-00135","article-title":"GC\/MS in recent years has defined the normal and clinically disordered steroidome: will it soon be surpassed by LC\/Tandem MS in this role?","volume":"2","author":"Shackleton","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.talanta.2026.130744_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464531","article-title":"Automated magnetic-bead-assisted sequential extraction technology for simultaneous detection of A\u03b21-42 and A\u03b21-40 in cerebrospinal fluid: an advance toward fully automated liquid chromatography-tandem mass spectrometry method","volume":"1713","author":"Zou","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.talanta.2026.130744_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117797","article-title":"Evolution of LC\u2013MS\/MS in clinical laboratories","volume":"555","author":"Yu","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2026.130744_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105553","article-title":"Urinary steroidomic profiles by LC-MS\/MS to monitor classic 21-Hydroxylase deficiency","volume":"198","author":"Pussard","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.talanta.2026.130744_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of Gallium-68 pentixafor positron emission tomography\u2013computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.talanta.2026.130744_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/clinem\/dgad421","article-title":"The value of targeting CXCR4 with 68Ga-Pentixafor PET\/CT for subtyping primary aldosteronism","volume":"109","author":"Zheng","year":"2024","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.talanta.2026.130744_bib39","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.eprac.2025.02.012","article-title":"Primary aldosteronism classification with 18-Oxocortisol and Gallium-68-Pentixafor positron emission tomography\/computed tomography","volume":"31","author":"Gao","year":"2025","journal-title":"Endocr. Pract.: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"key":"10.1016\/j.talanta.2026.130744_bib40","series-title":"Liquid chromatography-mass Spectrometry Methods; Approved Guideline","year":"2014"},{"key":"10.1016\/j.talanta.2026.130744_bib41","series-title":"User Verification of Precision and Estimation of Bias; Approved Guideline","year":"2014"},{"issue":"3","key":"10.1016\/j.talanta.2026.130744_bib42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1515\/cclm-2020-0410","article-title":"Measurement of serum 17-hydroxyprogesterone using isotope dilution liquid chromatography-tandem mass spectrometry candidate reference method and evaluation of the performance for three routine methods","volume":"59","author":"Long","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.talanta.2026.130744_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/cs0570409","article-title":"Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free\u2019) aldosterone in hypertension","volume":"57","author":"Abdelhamid","year":"1979","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.talanta.2026.130744_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clinbiochem.2015.11.004","article-title":"Sodium interference in the determination of urinary aldosterone","volume":"49","author":"Aldea","year":"2016","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.talanta.2026.130744_bib45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.talanta.2008.03.048","article-title":"Advantages of pentafluorophenylpropyl stationary phase over conventional C18 stationary phase\u2014Application to analysis of triamcinolone acetonide","volume":"76","author":"Havl\u00edkov\u00e1","year":"2008","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2026.130744_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124541","article-title":"Profiling neuroactive steroids in pregnancy. A non-derivatised liquid chromatography tandem mass spectrometry method for the quantitation of allopregnanolone and four related isomers in maternal serum","volume":"1256","author":"Hinchliffe","year":"2025","journal-title":"J. Chromatogr. B"},{"issue":"3","key":"10.1016\/j.talanta.2026.130744_bib47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/mas.20298","article-title":"An overview of matrix effects in liquid chromatography-mass spectrometry","volume":"30","author":"Trufelli","year":"2011","journal-title":"Mass Spectrom. Rev."},{"issue":"4","key":"10.1016\/j.talanta.2026.130744_bib48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.talanta.2026.130744_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00216-011-4779-8","article-title":"Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry","volume":"400","author":"Badoud","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2026.130744_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.128268","article-title":"An automated magnetic-bead-assisted liquid chromatography-tandem mass spectrometry method for analyzing angiotensins, ALD, and 18-OH derivatives: application of primary aldosteronism early screening and subtyping","volume":"295","author":"Li","year":"2025","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2026.130744_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123562","article-title":"LC-MS\/MS methods for the determination of 30 quaternary ammonium compounds including benzalkonium and paraquat in human serum and urine","volume":"1214","author":"Li","year":"2023","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"22","key":"10.1016\/j.talanta.2026.130744_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213858","article-title":"Comprehensive steroid assay with non-targeted analysis using liquid chromatography ion mobility mass spectrometry","volume":"23","author":"Yamakawa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.talanta.2026.130744_bib53","article-title":"Comprehensive quantitative urinary steroid profiling of 29 steroids using liquid chromatography\u2010tandem mass spectrometry","volume":"7","author":"Bain","year":"2026","journal-title":"Analyt. Sci. Adv."},{"issue":"6","key":"10.1016\/j.talanta.2026.130744_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9703","article-title":"A biomarker panel of secondary hypertension is simultaneously quantified by coupling of magnetic solid-phase extraction and liquid chromatography-tandem mass spectrometry","volume":"38","author":"Gao","year":"2024","journal-title":"Rapid Commun. Mass Spectrom.: RCM (Rapid Commun. Mass Spectrom.)"},{"issue":"2","key":"10.1016\/j.talanta.2026.130744_bib55","first-page":"802","article-title":"Novel magnetic-bead-assisted sequential extraction method for liquid chromatography-mass spectrometry (MS)\/MS of components with diverse properties: gastrin determination as a case study","volume":"95","author":"Ma","year":"2023","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.talanta.2026.130744_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.talanta.2026.130744_bib57","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41440-023-01347-2","article-title":"Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC\u2013MS\/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol","volume":"46","author":"Chang","year":"2023","journal-title":"Hypertens. Res."},{"issue":"7","key":"10.1016\/j.talanta.2026.130744_bib58","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/HYPERTENSIONAHA.123.20921","article-title":"Primary aldosteronism: spatial multiomics mapping of genotype-dependent heterogeneity and tumor expansion of aldosterone-producing adenomas","volume":"80","author":"Gong","year":"2023","journal-title":"Hypertension"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026014001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026014001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:30:40Z","timestamp":1793424640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914026014001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":58,"alternative-id":["S0039914026014001"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130744","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated enzymatic hydrolysis\u2013magnetic-bead-assisted sequential extraction workflow for LC\u2013MS\/MS profiling of urinary aldosterone-pathway steroids","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130744"}}